【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 8
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Endometriosis Overview 11
Therapeutics Development 12
Pipeline Products for Endometriosis – Overview 12
Pipeline Products for Endometriosis – Comparative Analysis 13
Endometriosis – Therapeutics under Development by Companies 14
Endometriosis – Therapeutics under Investigation by Universities/Institutes 17
Endometriosis – Pipeline Products Glance 18
Late Stage Products 18
Clinical Stage Products 19
Early Stage Products 20
Unknown Stage Products 21
Endometriosis – Products under Development by Companies 22
Endometriosis – Products under Investigation by Universities/Institutes 24
Endometriosis – Companies Involved in Therapeutics Development 25
AbbVie Inc. 25
Addex Therapeutics Ltd 26
APAvadis Biotechnologies Srl 27
Astellas Pharma Inc. 28
Bayer AG 29
Dongkook Pharmaceutical Co., Ltd. 30
ElexoPharm GmbH 31
EndoCeutics, Inc. 32
Euroscreen S.A. 33
Evotec AG 34
Forendo Pharma Oy 35
GlaxoSmithKline plc 36
Isifer AB 37
Kissei Pharmaceutical Co., Ltd. 38
Lipicard Technologies Limited 39
Neurocrine Biosciences, Inc. 40
Orphagen Pharmaceuticals, Inc. 41
Philogen S.p.A. 42
PregLem SA 43
Repros Therapeutics Inc. 44
SK Chemicals Co., Ltd. 45
Takeda Pharmaceutical Company Limited 46
ValiRx Plc 47
Endometriosis – Therapeutics Assessment 48
Assessment by Monotherapy Products 48
Assessment by Combination Products 49
Assessment by Target 50
Assessment by Mechanism of Action 52
Assessment by Route of Administration 54
Assessment by Molecule Type 56
Drug Profiles 58
(anastrozole + levonorgestrel) – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
acolbifene hydrochloride + GnRH agonist + prasterone – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
ADX-68692 – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
ASP-1707 – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
BAY-1026153 – Drug Profile 62
Product Description 62
Mechanism of Action 62
R&D Progress 62
BAY-1128688 – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
bentamapimod – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
Drug to Inhibit C-Jun for Endometriosis – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
Drug to Target RERG for Endometriosis – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
Drugs for Endometriosis – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
Drugs for Endometriosis and Uterine Fibroids – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
elagolix sodium – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
Endole – Drug Profile 71
Product Description 71
Mechanism of Action 71
R&D Progress 71
epelsiban besylate – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
ESN-364 – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
EVE-104 – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
F8IL-4 – Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
FP-5677 – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
goserelin biosimilar – Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
KLH-2109 – Drug Profile 80
Product Description 80
Mechanism of Action 80
R&D Progress 80
LT-6121 – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
Monoclonal Antibody to Antagonize Prolactin Receptor for Endometriosis – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
NCE-403 – Drug Profile 83
Product Description 83
Mechanism of Action 83
R&D Progress 83
Peptides for Cancer and Endometriosis – Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
Peptides to Inhibit Aminopeptidase A for Cancer and Endometriosis – Drug Profile 85
Product Description 85
Mechanism of Action 85
R&D Progress 85
PGL-2001 – Drug Profile 86
Product Description 86
Mechanism of Action 86
R&D Progress 86
Recombinant Protein for Endometriosis and Ovarian Hyperstimulation Syndrome – Drug Profile 88
Product Description 88
Mechanism of Action 88
R&D Progress 88
relugolix – Drug Profile 89
Product Description 89
Mechanism of Action 89
R&D Progress 89
Small Molecule to Antagonize GnRH for Endometriosis, Uterine Fibroids, and Oncology – Drug Profile 90
Product Description 90
Mechanism of Action 90
R&D Progress 90
Small Molecules to Antagonize Prostanoid EP2 and EP4 Receptors for Endometriosis – Drug Profile 91
Product Description 91
Mechanism of Action 91
R&D Progress 91
Small Molecules to Antagonize Steroidogenic Factor-1 for Endometriosis, Cancer and Cushing’s Disease – Drug Profile 92
Product Description 92
Mechanism of Action 92
R&D Progress 92
Small Molecules to Inhibit 17 Beta-HSD1 for Endometriosis – Drug Profile 93
Product Description 93
Mechanism of Action 93
R&D Progress 93
Small Molecules to Inhibit 17 Beta-Hydroxysteroid Dehydrogenase Type1 for Endometriosis and Estrogen Dependent Cancers – Drug Profile 94
Product Description 94
Mechanism of Action 94
R&D Progress 94
Small Molecules to Inhibit CD147 for Immunology, Oncology, Endometriosis and Arthritis – Drug Profile 95
Product Description 95
Mechanism of Action 95
R&D Progress 95
SR-16234 – Drug Profile 96
Product Description 96
Mechanism of Action 96
R&D Progress 96
Synthetic Peptide to Antagonize GPR54 for Womens Health, Male Health and Oncology – Drug Profile 97
Product Description 97
Mechanism of Action 97
R&D Progress 97
telapristone acetate – Drug Profile 98
Product Description 98
Mechanism of Action 98
R&D Progress 98
triptorelin pamoate biosimilar – Drug Profile 101
Product Description 101
Mechanism of Action 101
R&D Progress 101
VAL-201 – Drug Profile 102
Product Description 102
Mechanism of Action 102
R&D Progress 102
vilaprisan – Drug Profile 103
Product Description 103
Mechanism of Action 103
R&D Progress 103
VPE-001 – Drug Profile 104
Product Description 104
Mechanism of Action 104
R&D Progress 104
Endometriosis – Recent Pipeline Updates 105
Endometriosis – Dormant Projects 118
Endometriosis – Discontinued Products 120
Endometriosis – Product Development Milestones 121
Featured News & Press Releases 121
Apr 01, 2014: ValiRx Provides Updated On Anti-cancer Therapeutic VAL201 121
Mar 13, 2014: New drug candidate showed efficacy in human endometriosis samples 121
Oct 03, 2013: ValiRx Files Phase IB/dose escalation study for VAL201 121
Aug 29, 2013: Neurocrine Biosciences Announces the Start of Second Phase III Study of Elagolix in Endometriosis 122
Apr 25, 2013: ValiRx Receives Australian Patent For VAL201 123
Nov 13, 2012: Repros Presents Proellex Clinical Updates At Lazard Capital Markets 9th Annual Healthcare Conference 123
Oct 08, 2012: Repros Therapeutics’s Proellex Receives FDA Acceptance For Reclassification Of Clinical Hold Status 123
Aug 27, 2012: FDA Provides Recommendations For Phase II Protocol For Repros’ Proellex In Treatment Of Endometriosis 124
Jul 30, 2012: FDA Schedules Meeting With Repros To Discuss Phase II Protocol For Proellex For Treatment Of Endometriosis 125
Jul 16, 2012: FDA Provides Guidance To Repros For Conducting Phase II Study Of Proellex In Treatment Of Endometriosis 125
Appendix 126
Methodology 126
Coverage 126
Secondary Research 126
Primary Research 126
Expert Panel Validation 126
Contact Us 127
Disclaimer 127
【レポート販売概要】
■ タイトル：子宮内膜症(Endometriosis)の治療薬パイプライン動向（2015年上半期版）■ 英文：Endometriosis - Pipeline Review, H1 2015
■ 発行日：2015年1月22日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6032IDB
■ 調査対象地域：グローバル
- 前臨床イメージング（イン・ビボ）の世界市場：光学イメージング、PET、SPECT、CT、MRI、超音波、光音響イメージング、磁気粒子画像法、光学イメージング試薬、コントラスト剤、PETトレーサー、SPECTプローブThe global preclinical imaging market is expected to reach a value of USD 910.4 Million by 2021; growing at a CAGR of 6.2% during 2016-2021. A number of factors such as technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches …
- ゼオライトの世界市場：天然ゼオライト、合成ゼオライトAbout Zeolite Zeolites are alumina silicate and microporous minerals that are available naturally and also can be produced synthetically. They have a three-dimensional crystalline structure of tetrahedral arrangements of alumina or siliceous anions that are sturdily bonded at corners. The zeolite structure contains (–Si–O–Al–) linkages. These linkages form even sized pores on the surface and form …
- 移動式ミニ冷蔵庫の世界市場2016-2020About Portable Mini Fridge A portable mini fridge is the best option to keep food, beverage, medicines, and cosmetics cool while travelling. These mini fridges are smaller and lighter than conventional refrigerators. So, consumers can set them up wherever they want immediately after purchase. A light weight is a key property of these fridges. Due to this property, travelers install them in their v …
- 空港情報システムの世界市場：機能別/空港クラス別/コスト別/ソフトウェア別/地域別分析The global airport information systems market is estimated to be $2,420.32 million in 2014 and is expected to register a CAGR of 4.76% to reach $3,490.69 million by 2020. The report provides a market analysis of the global airport information systems market, over the next five years. It contains the analysis of drivers, challenges, restraints, and burning issues that impact the industry. It also d …
- リモコンの世界市場2016-2020About Remote Remotes/remote controls are devices used to wirelessly operate electronic gadgets such as TVs (including smart TVs), set-top boxes, and gaming consoles from a short line-of-sight distance. Users typically use a remote to adjust various settings such as tracking number and volume. There are two popular types of remote controls mostly used by customers: IR remotes and RF remotes. IR rem …
- スマート鉄道の世界市場予測（～2021）：乗客情報、貨物情報、鉄道通信、先進セキュリティモニタリング、鉄道分析The smart railways market size is estimated to grow from USD 10.50 Billion in 2016 and to USD 20.58 Billion by 2021, at a CAGR of 14.4% from 2016 to 2021. Some of the major factors that are driving the growth of the market include the demographic growth & hyper-urbanization, demand for improved service quality, telecom-based technological growth, and emergence of IoT technology. The scope of this …
- デジタル資産管理の世界市場分析：タイプ別（ソリューション、サービス）、展開別（オンプレミス、クラウド）、用途別（セールス、マーケティング、IT）、エンドユーザー別（BFSI、小売、ヘルスケア）、セグメント予測、2014-2025The global digital asset management market is expected to reach USD 5.60 billion by 2025, according to a new report by Grand View Research, Inc. The market is anticipated to witness a healthy growth, ascribed to the increasing preference by organizations for rich media content for promoting brands and products. Further, the rising adoption of portable devices in enterprises has increased security …
- MRIシステムの世界市場2019-2023About this market Focus on development of helium-free MRI systems to drive market growth. Helium is an essential component in MRI systems. There is severe shortage of helium worldwide. However, the demand has been significantly increasing over the past decades. This results in increasing manufacturing costs of the MRI systems. To overcome this, vendors are focusing on the R&D of helium-free MRI sy …
- 加齢黄斑変性(AMD)：世界の臨床試験レビュー（2014年上半期）Age Related Macular Degeneration Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Age Related Macular Degeneration Global Clinical Trials Review, H1, 2014" provides data on the Age Related Macular Degeneration clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Age Related Macular Degeneration. It inclu …
- 乾癬治療薬の世界市場予測・分析PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024 Summary Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report. Although not life-threatening, Psoriasis causes tremendous morbidity and person …
- 自動販売機の世界市場2019-2023About this market The rise in adoption of intelligent vending machines to propel growth in the market. Unlike conventional vending machines that just dispense products, intelligent vending machines have advanced features such as operations and inventory management, customer analytics, transaction management, software and platform management, and digital advertising and content management systems. …
- パッケージ印刷の世界市場：インキ種類（水性インキ、紫外線硬化インキ）、印刷技術、パッケージ材料、用途、地域別分析The packaging printing market includes several types of printing technology such as flexography, rotogravure, offset, digital, and others. The packaging printing market has varied applications, such as cosmetics & toiletries, food & beverages, healthcare, and others. Packaging printing offers wide range of benefits such as enhanced aesthetic appeal, better communicability, and protection from coun …
- 世界のスマートテレビ（Smart TV）市場動向（2014-2018）TechNavio's analysts forecast the Global Smart TV market to grow at a CAGR of 21.06 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased spending on consumer electronic goods. The Global Smart TV market has also been witnessing the increasing adoption of smart TVs in advertising. However, the presence of multiple smart TV platforms could pos …
- Hemostasis：グローバル臨床試験レビューH2, 2013Hemostasis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Hemostasis Global Clinical Trials Review, H2, 2013" provides data on the Hemostasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemostasis. It includes an overview of the trial numbers and their recruitment status as per the site of tri …
- 世界のバイオ農薬市場動向（2012-2016）TechNavio's analysts forecast the Global Biopesticides market to grow at a CAGR of 15.87 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased consumption of organic food products. The Global Biopesticides market has also been witnessing an increasing demand for sustainable agricultural practices. However, government regulations that deter bi …
